NQO1 and cancer: Appreciating this,Nishimoto and co-workers prepared the theranostic agent 32a (Figure 14) designedto deliver the cytotoxin SN-38 to cancer cells.186 DT-diaphorase mediated-reduction was then expected to releasethe active SN-38 drug with concomitant fluorescence changes.